UY33584A - NEW BENZAMIDA COMPOUNDS OF LRRK2 INHIBITORS - Google Patents

NEW BENZAMIDA COMPOUNDS OF LRRK2 INHIBITORS

Info

Publication number
UY33584A
UY33584A UY0001033584A UY33584A UY33584A UY 33584 A UY33584 A UY 33584A UY 0001033584 A UY0001033584 A UY 0001033584A UY 33584 A UY33584 A UY 33584A UY 33584 A UY33584 A UY 33584A
Authority
UY
Uruguay
Prior art keywords
compounds
benzamida
new
lrrk2 inhibitors
lrrk2
Prior art date
Application number
UY0001033584A
Other languages
Spanish (es)
Inventor
Andrew John Eatherton
Daniele Andreotti
Karamjit Singh Jandu
Oliver James Philps
Liu Qian
Dai Xuedong
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of UY33584A publication Critical patent/UY33584A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos que inhiben la actividad quinasa de LRRK2, a procedimientos para su preparación, a las composiciones que los contienen y a su uso en el tratamiento de enfermedades caracterizadas por la actividad quinasa de LRRK2, por ejemplo la enfermedad de Parkinson o la enfermedad de Alzheimer.The present invention relates to novel compounds that inhibit the kinase activity of LRRK2, to methods for its preparation, to compositions containing them and to their use in the treatment of diseases characterized by the kinase activity of LRRK2, for example Parkinson's disease or Alzheimer's disease.

UY0001033584A 2010-09-02 2011-08-31 NEW BENZAMIDA COMPOUNDS OF LRRK2 INHIBITORS UY33584A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN10076557 2010-09-02
CN2011000511 2011-03-28
CN2011001227 2011-07-26

Publications (1)

Publication Number Publication Date
UY33584A true UY33584A (en) 2012-03-30

Family

ID=45922894

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033584A UY33584A (en) 2010-09-02 2011-08-31 NEW BENZAMIDA COMPOUNDS OF LRRK2 INHIBITORS

Country Status (1)

Country Link
UY (1) UY33584A (en)

Similar Documents

Publication Publication Date Title
CL2017002650A1 (en) Novel compounds
DOP2016000195A (en) COMPOUNDS
CO6620050A2 (en) Aminopyrimidine derivatives as modulators of lrrk2
UY33241A (en) ? Tienopyrimidines containing heterocycloalkyl for pharmaceutical compositions ?.
ECSP13012611A (en) PIRAZOL-AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2
ECSP12012318A (en) PIRAZOLIL QUINAZOLINA CINASA INHIBITORS
CR20190156A (en) Bipyrazole derivatives as jak inhibitors
UY33245A (en) TIENOPIRIMIDINES CONTAINING A SUBSTITUTED RENT GROUP FOR PHARMACEUTICAL COMPOSITIONS
UY33246A (en) TIENOPIRIMIDINES CONTAINING CYCLLOQUAL FOR PHARMACEUTICAL COMPOSITIONS
DOP2013000130A (en) PIRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS THROUGH LP - PLA2
CU20130115A7 (en) COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
CO6450612A2 (en) SUBSTITUTED 1-CYANOETHYLETHYCLIC CARBOXAMIDE 750 COMPOUNDS
UY33950A (en) BENZODIOXAN INHIBITORS OF LEUCOTRENE PRODUCTION
CR20120264A (en) COMPOUNDS
UY36224A (en) TRICYCLIC COMPOUNDS OF IMIDAZO-PIRIMIDINONA
UY33337A (en) SUBSTITUTED DERIVATIVES OF 1H-PIRAZOL [3,4-d] PYRIMIDINE AS INHIBITORS OF PHOSFOINOSITIDE 3-KINASES
AU2012258977A8 (en) Inhibitors of LRRK2 kinase activity
CR20150390A (en) IODOPROTEIN INHIBITORS BASED ON 2,3-DIHYDROIMIDAZOL [1,2-C] PYRIMIDIN-5 (1-H) -ONA-ASSOCIATED WITH PHOSPHOLIPASE A2 (LP-PLA2)
UY34955A (en) 4-METHYL-2,3,5,9,9B-PENTAAZA-CICLOPENTA [A] NAFTALENOS
UY33655A (en) CCR30 CO-CRYSTALS AND SALES OF INHIBITORS
ECSP14013215A (en) NEW COMPOUNDS
BR112014000792A2 (en) Piperidinyl Compounds for Use as Tanquirase Inhibitors
DOP2015000170A (en) CHEMICAL COMPOUNDS
UY31922A (en) COMPOUNDS
UY36875A (en) BROMODOMINIUM INHIBITING COMPOSITIONS FOR THE TREATMENT OF VARIOUS DISEASES